Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
You'll get FREE Breaking News Alerts on new MS treatments as they are approved

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

This page is powered by Blogger. Isn't yours?



VIDEO: New MS database could change practice


Genmab Announces Ofatumumab Development Plans in RRMS


Drug-induced thrombocytopenia secondary to Tysabri (natalizumab) treatment


Sodium Buildup In Brain Linked To MS


Empowering Patients with Multiple Sclerosis to Follow Their Own Path to Pain Relief


Correcting vitamin D deficiency early in Betaseron (interferon beta-1b) treatment may reduce MS disease activity


Gastro Effects Dog Oral MS Drug Tecfidera: one-quarter of patients switching to dimethyl fumarate from another MS medication in an independent study had stopped the drug within 3 months

Large proportions of patients starting on dimethyl fumarate (Tecfidera) for multiple sclerosis appear to need additional medications to manage the drug's gastrointestinal and other adverse effects, and a substantial minority are ultimately unable to tolerate the drug, multiple studies reported here found.

These findings were confirmed in the manufacturer's own studies -- for example, more than half of patients in an open-label study took over-the-counter medications to control stomach upset and diarrhea -- although symptoms eventually abated in those who stayed on the drug beyond 2 months.

But more mundane side effects such as flushing, gastrointestinal complaints, and itching were common.

Story Source: The above story is based on materials provided by MEDPAGE TODAY
Note: Materials may be edited for content and length

Labels: ,


Researchers found that people with multiple sclerosis who exercise have a lower risk of relapse in comparison with other MS patients who did not exercise


Could MSers use a less expensive version of this: A new suit for the firefighter of the future has been revealed that could give them superhuman strength

The exoskeleton would allow firefighters to easily rescue and carry people out of fires, or take heavy equipment up flights of stairs inside a burning building
Click here to read


'Gym selfies' for Kiss Goodbye to MS Campaign



A Study of NeuroVax: a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis -


What Causes Memory Problems?


Is Medical Marijuana an Effective Option for Patients with Multiple Sclerosis?

Medical marijuana has come of age and doctors will need to be more accepting of the idea that patients with multiple sclerosis may soon be requesting a prescription
Click here to read more



Health care practitioners are learning that vitamin D is vital in caring for fibromyalgia, multiple sclerosis and Parkinsons: CBS News


Study: Abnormal inflammatory activity returns after Tysabri (natalizumab) cessation in multiple sclerosis


Pharma giants investing to hold market share in MS treatment market


Strategies for Selecting the Most Effective Treatment for Pain in Patients with Multiple Sclerosis


New Ways to Define Multiple Sclerosis Could Change Treatment - EmaxHealth

Now a 32-member advisory team, which is part of the International Committee on Clinical Trials of MS, has recommended some changes to the existing phenotype definitions. Here are some of the suggestions
Click here to read more


William R. T. Boulton, Author of book ‘I Miss Me’ talks about his MS


Biogen Idec Announces Official Partnership with Sailing Sclerosis´ "Oceans of Hope" to Globally Change Perceptions of MS



Against the odds Jess riding out to inspire others


Hemp Oil: The Science Behind The Healing | Deep Dot Web


Bethany Lamont is abused over disabled parking with her MS


Man in his 20s lives with MS, in seniors facility and without much money


Multiple Sclerosis Health Quiz


Nintendo Wii as Therapy and Fun for Multiple Sclerosis


Mount Sinai Researchers Lead International Advisory Committee To Define The Clinical Course of Multiple Sclerosis


Clay Walker Prepares for Fifth Annual “Chords of Hope” Concert Tuesday June 3rd


"The stem-cell revolution targeting leukemia" IS MULTIPLE SCLEROSIS NEXT?



California goes after Teva, Johnson & Johnson and other drugmakers over opioids

California has decided to lay the responsibility for opioid overdoses, and even a resurgence in heroin use, at the feet of the drugmakers, accusing them in a lawsuit of reaping huge profits while turning a large swath of people into drug addicts
Click here to read more


Smart meters: Are they safe? MSer is worried about how the installation of 15 smart meters next to her condo could impact her health


MSer is going to Russia for hematopoietic stem cell transplant


Specialist training increases medics' knowledge of multiple sclerosis: all hospitals should do this


Imaging scientists develop a better tool for tracking MS


Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test

Study Conclusion: Our data suggest that ambulation tests using Microsoft KinectTM are feasible, well tolerated and can detect clinical gait disturbances in patients with MS. The retest-reliability was on par with the T25FW.
Click here to read more

Labels: ,


British MSers to get new MS drug Lemtrada (Alemtuzumab): Treatment not only stops the disease from advancing but may help patients recover from disability

Lemtrada (Alemtuzumab) infusion is given in two short courses over two years
Click here to read



The Most Promising Antioxidant You Never Heard Of and it's connection to Multiple Sclerosis


Study links 'bad fat' levels in blood to progress of multiple sclerosis


Medical Marijuana for Neurologic Diseases

We found that certain forms of marijuana -- pills and oral spray, primarily -- were useful in treating some systems of multiple sclerosis, especially spasticity, pain, central pain and painful spasms, and overactive bladder. Medical marijuana was not found to help tremor in multiple sclerosis, nor did it reduce other bladder symptoms. There wasn't enough information to comment on whether smoked marijuana was useful. There were only 2 studies, and no conclusions could be reached from them.
Click here to read





Study: Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study

"Our data indicate no association between paternal DMD exposure at time of conception and risk of spontaneous abortion, adverse fetal outcomes and congenital malformations"
Click here to read



MS Run organizer Rory Marriott struck down by multiple sclerosis thanks mom-of-two for ‘becoming my legs’


Teva Pharmaceutical Industries Ltd. Gets a Taste of its Own Medicine




"Paralyzed MSer raided by SWAT, sentenced to 25 years for possessing his own medicine"

FLORIDA — "A wheelchair-bound man, suffering from paralysis, severe chronic pain, and multiple sclerosis, was raided by masked, gun-wielding agents and ultimately sentenced to 25 years in prison for possessing a one-month supply of his own doctor-prescribed painkillers. Mandatory minimum sentencing laws enabled this to happen, and remain a dangerous threat to the freedom of Americans who have never been accused of a violent crime"
Click here to read more


Ampyra's effects on walking ability in MS extend to 24 weeks

Ampyra was shown to improve walking ability and balance in patients with progressive and relapsing-remitting multiple sclerosis, according to data presented at the annual meeting of the American Academy of Neurology.
Click here to read more

Labels: ,


Biogen gets positive opinion for new Plegridy multiple sclerosis injectable treatment


2 MAYORS WITH MS GET TOGETHER AND DISCUSS: Living Positively with Multiple Sclerosis



VIDEO: Heather Drew plays at the highest level while battling MS

Heather Drew graduated from the University of Arizona and went on to spend 16 years on the LPGA Tour
Click here to see

Labels: ,


Good News On Pregnancy And Multiple Sclerosis


Flashy paint jobs, sparkling chrome: Motorcycles for Multiple Sclerosis


Pharmacy Choice - Pharmaceutical Bayer Introduces First Bluetooth-enabled Injection Management System for Multiple Sclerosis Patients on Betaseron




EU again turns down Teva's laquinimod

Teva and Active Biotech filed a request for a review of the finding. The result is a setback for the two companies. Laquinimod has been considered a replacement for Teva's high-selling multiple sclerosis treatment Copaxone
Click here to read more

Labels: ,


Interesting story about Shirley Temple's brother: A PRO WRESTLER WITH MS


MORE VITAMIN D NEWS FOR MSers: Low Vitamin D Levels Linked to More Severe Multiple Sclerosis


Scary Thoughts in Mice Fade on Novartis Multiple Sclerosis Drug Gilenya

Traumatic memories that haunt people with post-traumatic stress disorder might be eased by a pill from Novartis AG now used to treat multiple sclerosis, a study of mice suggests.
Click here to read more



Freddie, eight, raises money for his grandmother with MS



Russell W Brain and the aetiology of multiple sclerosis—a historical perspective


Meet the MSer who is the dog whisperer: Branford’s Michelle McAdam shares her secrets in canine communication


VIDEO: Body's 'safety procedure' could explain autoimmune disease

Professor Fabienne Mackay

Researchers have found an important safety mechanism in the immune system that may malfunction in people with autoimmune diseases, such as Multiple Sclerosis, potentially paving the way for innovative treatments. Published today in Immunity, the research, led by Head of the Monash Department of Immunology Professor Fabienne Mackay, described for the first time how the body manages marginal zone (MZ) B cells, which form a general first line of attack against germs, but are potentially harmful.
Click here to see



MS Learn Online with videos on Ampyra, Med. Marijuana, etc.

(Posted by Desinie Smith - " There are lots of great videos on this MS Learn Online series about Medical Marijuana, Ampyra, Yoga, Tai Chi, Relaxation Methods, various rehab options, and side effects of corticosteroids. See all the videos on the right side of the page.")
Click here to see

Labels: , , ,


VIDEO: "Jack Osbourne sits down with Dr. Oz to talk about the MS diagnosis that changed his life"

For the first time, Jack Osbourne sits down with Dr. Oz to talk about the MS diagnosis that changed his life. He reveals how he’s taken charge of his health and how you can do the same! Plus, discover the new low-carb flours that will let you have your cake and lose weight too! 
Click here to view videos: Parts 1 to 3



AAN: Nimble Activity Protects Against Mild Cognitive Impairment

SEATTLE, Feb. 18 -- Middle-age and older adults who prefer a mental workout to passive activities, such as watching TV, may be less likely to develop memory loss as they age, researchers said.

Mentally stimulating social activity and reading in middle age reduced the likelihood of mild cognitive impairment in old age by more than 40%, found Yonas E. Geda, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues.

Read more »

Labels: , ,


Videographer and artist team up for documentary short

When Cheryl Bowlan met Elizabeth Jameson a decade ago, Bowlan remembers it was the beginning of a union of like minds poised for a higher calling — to serve as public interest artists — using art to create awareness of worthwhile causes.

So Jameson, a Lafayette resident, turned to painting after multiple sclerosis prevented her from continuing her law career. Bowlan, also of Lafayette, shifted from a communications and marketing field to becoming a public interest videographer and multimedia producer.
Read more »



'Fantastic' photos show hidden side of MS


'I know I can do it' Proving that Multiple Sclerosis need not be a barrier to fitness


Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis


Blood miRNA expression pattern is a possible risk marker for Tysabri-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis patients


An observational comparison of Tysabri vs. Gilenya using JCV serology to determine therapy


Depression in multiple sclerosis: A long-term longitudinal study


Teva keeps the faith after another rebuke for Copaxone's MS heir: Laquinimod


Biogen Idec nearing finish line on new MS drug Plegridy that will be manufactured in US

Biogen Idec received a positive recommendation from a European agency on its potential new drug Plegridy, a good sign in receiving final approval to market the drug in the European Union.
Click here to read more



Iran’s religious dress code, contributing to rise of Multiple Sclerosis among women


Group memory rehabilitation for people with multiple sclerosis: a feasibility randomized controlled trial



Physical Therapy and MS – An Essential Partnership


Slow-growing plant yields marijuana designed for sick kids

Preparing Charlotte’s Web is a protracted, tedious process that starts at "the grow," two massive greenhouses on 56 acres of spring-fed land at an undisclosed location in the mountains.

Read more »


What are TENS? They might help MS





Imatinib Receives Orphan Drug Designation for treatment of Progressive Multifocal Leukoencephalopathy (PML)


Pregabalin versus Pramipexole for Restless Legs Syndrome


'This is my medicine': MSer urges NY to pass Compassionate Care Act, legalize medical marijuana


New USC center, the first of its kind, aims to restore neurological function in the human brain


VIDEO: The journalist Richard Cohen, husband of NBC special correspondent Meredith Vieira, joins TODAY to talk about living with multiple sclerosis and participating in a clinical trial in hopes of finding a cure for his disease


7 Health Risks Linked to Multiple Sclerosis: Important Ways to Safeguard Your Health if You Have MS


LEMTRADA/Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy


Josh Harding who is under under contract to the Minnesota Wild hockey team ’til 2015, at $1.9 million per, might not be healthy enough to return, as complications from a change in multiple sclerosis treatment forced him to miss the second half of the season and playoffs.


MSer makes lemonade from her sour diagnosis



India, China to witness high growth of multiple sclerosis: Number of MS prevalent cases across ten major markets will increase from 904,908 in 2013 to 940,413 by 2023


Space scientist & MSer Colin Pillinger has had a mountain feature on Mars named after him by NASA: The US space agency has been steering a robotic rover called Opportunity on Mars and has christened a rocky ridge Pillinger Point.


Botox Might Help Treat Bladder Disorders


New data identify an increasing sex ratio of multiple sclerosis in Sweden


Glutathione in multiple sclerosis: More than just an antioxidant?


Characterizing cognitive function during relapse in multiple sclerosis: STUDY


Why I'm Short Synthetic Biologics After Phase II Relapsing-Remitting Multiple Sclerosis Data


Safety and Efficacy of Tysabri (Natalizumab) in Russian Participants With Relapsing Remitting Multiple Sclerosis: STUDY


Missing woman with multiple sclerosis, anxiety and depression found trying to cross into Mexico


Physical therapy helps implement brain reorganizational training to improve gait disorders in patients with multiple sclerosis


Beekeeper with multiple sclerosis dies after being stung by bees 40 times in her backyard





VIDEO: Dr. Emmanuelle Waubant, professor of neurology at the University of California, San Francisco, talks about progress being made with Multiple Sclerosis therapies and discusses 3 investigational drugs that could reach the market soon


"Coffee Could Prevent Multiple Sclerosis"

A study found that caffeine can protect brain cells from damage in multiple sclerosis. The findings of the study conducted on mice by the scientists at the Oklahoma Medical Research Foundation will be published in the July 8 issue of the journal Proceedings of the National Academy of Sciences, the results have already been presented at the 95th Annual Meeting of the American Association of Immunologists in San Diego, which took place this year in April.

Read more »


Children's and adolescents adjustment to parental multiple sclerosis: a systematic review

4 to 12% of children live in households where a parent has a chronic illness
Click here to read more






Glatiramer acetate (Copaxone) –induced acute hepatotoxicity in an adolescent with MS


Epstein-Barr virus infection is associated with multiple sclerosis (MS). One recent study found that “Patients with multiple sclerosis (MS) have elevated antibodies against Epstein-Barr virus




Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis





Read more »

Labels: , ,




VIDEO FOR DOCTORS & NURSES: The panelists discuss why treating multiple sclerosis (MS) is complex


VIDEO: Charting Progress in MS Treatment: Initiating, Monitoring, and Switching Disease-Modifying Therapy



Jake Evans works full-time with the Multiple Sclerosis Society during off-seasonsClick here to see



New York Times Video


VIDEO FOR DOCTORS: Episode 1 - The Changing Tides of Multiple Sclerosis: Where Do We Currently Stand?

In a discussion moderated by Dr. Fred Lublin, Drs. Patricia K Coyle, Leslie Fish, and Gary M. Owens share their insights and perspectives on the increasing prevalence and incidence of multiple sclerosis (MS) worldwide, despite great clinical strides in recent years.
Read more »

Labels: ,


VIDEO: Daniel Kantor, MD, Addresses Risk Management in New Multiple Sclerosis Agents




Nasal Vaccine May Be Effective for Secondary Progressive MS


Shemar Moore of Criminal Minds Talks Mom's Battle With MS


New findings from mice may rewrite our understanding of just about everything myelin-related. Outside experts describe the study as “landmark,” “novel,” “unexpected,” “new,” “important,” “surprising,” “stunning,” and “provocative.”


Customizing antibodies for MS by learning from sharks


Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab


MSer gearing to race in the Daytona 500



Momenta overcomes hurdle to launch generic Copaxone and reversed a four month stock slide today after a last-ditch lawsuit by a competitor to stave off generic versions of a multiple sclerosis drug failed - despite that fact that Momenta hasn't revealed when it plans to launch the drug


VIDEO: Interview With the President: President Obama answers your health care reform questions about the rising costs of employer plans, why some plans have high deductibles, the Medicaid expansion, and more.


VIDEO: MSer on benefits for 14 years allowed to rack up $69,000 of debt


VIDEO: MRI Scans and MS

Doctors discuss the increased utilization of magnetic resonance imaging (MRI) scans and its impact in multiple sclerosis
Read more »



VIDEO: Dr. Travis Stork explains the latest research on multiple sclerosis


VIDEO: Patricia Coyle, MD, Discusses Treatment of Multiple Sclerosis


MSer sues Georgia city over law banning sex toys, says they saved her marriage after multiple sclerosis destroyed her nervous system and her sex life: The city ordinance only allows residents to buy sex toys if they have a prescription for them


“The Mice Are Walking” – New MS Treatment in the Works?


Do Bee Stings, Cobra Venom, Hypnotherapy, Reiki Work for MS?


Dementia in MS complicated by coexistent Alzheimer disease


Striking a Nerve: Science, Hype in MS Stem Cell Trials

With a new mouse study out Thursday suggesting that stem cells could be a treatment for multiple sclerosis, many neurologists are likely to face more questions from patients about stem cell therapies.
For now, the answer will probably be, please try to be patient.
In the new study, researchers led by Jeanne Loring, PhD, of the Scripps Institute in La Jolla, Calif., and Thomas Lane, PhD, of the University of Utah (where he recently relocated from the University of California Irvine), found that infusion of human neural precursor cells partially restored walking ability in mice with a virally-induced demyelinating condition resembling MS.
The neural precursors, which were derived from a human embryonic stem cell line, also appeared to induce remyelination of damaged nerve fibers, the researchers reported in Stem Cell Reports.
But in addition to the obvious caveats about animal studies, this one may bear extra caution because of the unusual model.
Most animal research on MS involves experimental autoimmune encephalomyelitis or EAE, which is induced by injecting mice with myelin basic peptide to provoke an anti-myelin immune attack. It more closely resembles the human disease than most animal models of other conditions.
Read more »



A Pilot Study Investigating the Short-Term Effect of Aerobic Exercise on Symptoms in Multiple Sclerosis and Chronic Fatigue Syndrome



Doctor who misdiagnosed a tumor in a multiple sclerosis patient and was fined $10,000 is now accused of groping patients and misdiagnosing Multiple Sclerosis


Coachella resident uses diet to combat rare form of multiple sclerosis


OMG OF THE WEEK: "Registered nurse says she recovered from multiple sclerosis by shunning medicine and instead following health principles traced back to the Bible"


Low-fat diet lifts MS fatigue


NEWS FROM THE AAN ANNUAL MEETING: PET Imaging Enables Better Differentiation of Lesions in Secondary Progressive MS


MSer's car is crushed as he lay in hospital bed


Multiple sclerosis: Vitamin D might combat multiple sclerosis by blocking migration of immune cells to the brain


SLIDESHOW: 6 Supplements to Consider for Multiple Sclerosis


Drug giant Mylan Inc. cheered a ruling by the U.S. District Court for the District of Columbia against rival drug maker Teva, which smooths the way for sales of a generic Copaxone



Doctor with MS tells how visible and invisible barriers inhibit healthcare access for disabled patients


Meredith Vieira and husband Richard Cohen will be co-keynote speakers and honorees for their work in raising awareness in the fight against MS


Dallas football coach with multiple sclerosis is improving thanks to stem-cell treatments


The Role of Rehabilitation in Multiple Sclerosis


Brittany does her part to help kiss goodbye to MS


STUDY: Modelling the natural history of primary progressive multiple sclerosis


In Australia, the US and Canada MS drugs are prescribed at the first diagnosis but in New Zealand signs of disability have to be shown before a treatment is prescribed so sports star quits and moves his MSer wife to Japan



Here it is...the 4th installment of my Stem Cell Journey for Multiple Sclerosis...PLUS MY VIDEO!

Judi Lecoq, Columnist, MS News Channel
We are back for the 4th installment of my Stem Cell Journey for Multiple Sclerosis.  So if you have read my previous columns (and I hope you have), you understand by now that Stem Cells are not a cure.  Understanding that the immune system modification period can last up to 9 months, sometimes less, a re-boot is good.  In other words for me, I try to keep that immune system modified as much as possible to keep the disease from moving.  This is where I chose to spend my medical dollars, since I do not use any disease modifying drugs or allopathic medicines at all.  I use all natural stuff, supplements and I
Read more »

Labels: , ,


Celebrities With Multiple Sclerosis: 14 PHOTO SLIDESHOW


Rock Against MS Auctioning Items Signed by Doors, Guns & Roses, KISS Members


STUDY: Interferon beta treatment of multiple sclerosis increases serum interleukin-7


Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis


Safety and Efficacy in Pediatric MS Patients Prescribed


Inovio Pharmaceuticals Inc. announced it acquired worldwide rights for early preclinical therapies addressing Alzheimer's disease and multiple sclerosis


Can I receive Social Security Disability benefits for Multiple Sclerosis?


Researchers at the Doorstep of Stem Cell Therapies for MS


Can a doctor who prescribes medical marijuana be held liable if a patient is involved in an automobile accident? A Canadian physician recently posed that question!



Elizabeth Smart tells MSers what her ordeal taught her


Awareness musical project Progmium: The brainchild of multiple sclerosis warrior Tim Surkovich




AN IMPORTANT LESSON FOR ALL DOCTORS: The right information and the proper tools to analyze it to improves our ability to care for patients!


GREAT NEWS FROM THIS HEADACHE STUDY: Simple screening tool improves headache management plus significantly increased headache diagnoses and triptan prescriptions, and significantly decreased opioid prescriptions


Playing Golf with Multiple Sclerosis


Tysabri (Natalizumab) Use During the Third Trimester of Pregnancy: STUDY


If New York State legalizes medical marijuana this spring, it will be the 22nd state MSers can have access to Medical Marijuana


Is Europe Way Ahead of the U.S. in Its Commitment to MS Care?



VIDEO: 'Dallas Buyers Club' connects with MSers

The book by Charles Fox, "With a Little Help from My Friends: A Love Story" is very similar because Fox had Multiple Sclerosis & fought for more than 30 years to get interferon to treat himself.

The Dallas Buyers Club and Charles Fox's account raises the issue of how drug regulation and in particular the FDA works. It is clear the FDA has a mandate to protect the citizens of the US from harmful drugs, however, the process of drug development is so painfully slow that if you have diseases such as AIDS or MS the delays in getting effective drugs to market means that many people died or became disabled waiting, sometimes in vain, for access to the relevant drugs.
Read more »



VIDEO: New Research on Multiple Sclerosis from The Doctors


Four times more women than men diagnosed with MS


Improper health care in Tennessee prison system led a MS sufferer wheelchair bound and skeletal


Study: New technology can now see damaged brain tissue through the eye


LEMTRADA: MSer wants to share his 'miracle'


Kelly Osbourne Shaves Her Head


Teva CFO: Don't eulogize Copaxone yet


STUDY: Tysabri (Natalizumab) to Gilenya (fingolimod) washout in patients at risk of PML

Upon withdrawing natalizumab, resumption of disease activity was soon observed, beginning 3–4 months after the last dose of natalizumab
Read more »

Labels: , , , ,


Multiple Sclerosis and Spray Marijuana, an Important Update

Anyone who has multiple sclerosis and who has thought about using marijuana for symptom relief, especially for spasticity, should consider the results of three new reports on the oromucosal spray marijuana (Sativex®).
Read more »

Labels: ,


Solid growth from Tecfidera (Dimethyl fumarate) in the US and OUS

"We expect solid growth from Tecfidera in the US and OUS," the biotech team said. "Consensus OUS Tecfidera sales estimates are conservative compared to Gilenya’s launch trajectory and we expect upward revisions.
Click here to read more

Labels: ,



VIDEO: Characterizing Multiple Sclerosis

Fred Lublin, MD, defines the 4 subtypes of MS: relapsing-remitting MS, secondary-progressive MS, primary-progressive MS, and progressive-relapsing MS and Patricia K. Coyle, MD, joins the discussion and describes the relationship between clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) to MS
Click here to watch video



VIDEO: Romanian bees still creating a buzz in health industry for MS


Walking Mice Kick Off New Area of MS Stem Cell Research


Accelerometer cut-points derived during over-ground walking in persons with mild, moderate, and severe multiple sclerosis


Adverse lipid profile is not associated with relapse risk in MS: Results from an observational cohort study


MSer offers $50,000 reward for stolen cattle


Heart Disease Risk For Inactive Women with Multiple Sclerosis After Age 30


Finally, a children's book about MS: Zowie Bowie Sings Despite All Sad Things arrives


Kelly Osbourne's Proud of Her Bro Jack



VIDEO: New PET Probe for Myelin in MS

Researchers have developed and are testing a promising new imaging technique that could eventually help diagnose and monitor treatment in patients with multiple sclerosis (MS).
New evidence in mouse models showed that the target-specific molecular probe, which uses positron emission tomography (PET) imaging, can detect and quantify myelin damage as well as monitor the efficacy of drug treatments.
Read more »



VIDEO: Why multiple sclerosis strikes mostly females may be linked to protein


VIDEO: ABC News - The Sleep Whisperer Can Help MSers Get to Sleep

Read more




The government alleged that two neurologists in the Baptist Health network intentionally misdiagnosed patients with neurological disorders which caused Baptist Health to bill for medically unnecessary services.

The alleged fraud involved misdiagnoses by two neurologists who told patients they had Multiple Sclerosis, etc.

Click here to read more



Gut Bacteria Can Affect Onset of Multiple Sclerosis

Gut bacteria, previously considered benign, has the ability to alter the immune system of mice enough to affect the rate of Multiple Sclerosis occurrance. In addition to a genetic component, neuroscience researchers must also figure in the gut bacteria’s influence over the immune system when studying the early stages of Multiple Sclerosis. This research will be valuable to scientists searching for Multiple Sclerosis treatments.
Click here to read more


Lawmakers vote to create Multiple Sclerosis Task Force


Study: Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality


Automated identification of brain new lesions in multiple sclerosis using subtraction images


Run in a Dress for MS fundraiser set Saturday



VIDEO: Triathlete with Multiple Sclerosis continues to compete, and win


Promising New Version of an Old MS Drug Can Be Taken Twice a Month


Study: Incidence of the urological tumours in patients suffering from multiple sclerosis


Marijuana lessens painful spasms of multiple sclerosis, studies find


Long-acting interferon-beta cuts relapse rate in multiple sclerosis


Teva Announces COPAXONE Recognized as “Brand of the Year” by Pharmaceutical Executive Magazine


Mouse study offers new clues to cognitive decline


MSer & Scientist behind Beagle 2 Mars rover, dies aged 70


Study: Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis


Is This Why Multiple Sclerosis Is More Common In Women?


Is isolated optic neuritis benign MS?


Ford will build a single 2015 Mustang 50 Years Anniversary convertible for raffle, with proceeds to support multiple sclerosis research



ECTRIMS Congress 2013: Oral MS drug Gilenya® shows up to 71% reduction in annualised relapse rates

 ECTRIMS Congress 2013

Novartis showcases data from 13 abstracts on Gilenya (fingolimod)

The data being presented for fingolimod at ECTRIMS/ACTRIMS highlight the Novartis clinical trial program for sphingosine 1-phosphate receptor (S1PR) modulators. Fingolimod targets MS via effects on the immune system and new pre-clinical data to be presented at ECTRIMS/ACTRIMS supports an
Read more »



Data Show Declining Use of Injectables as Oral Multiple Sclerosis Therapies Gain Traction

Genzyme’s new multiple sclerosis drug Aubagio (teriflunomide) has received final guidance recommendation from the National Institute for Health and Care Excellence (NICE).  The National Health Service (NHS) is induced to a legal obligation to begin funding treatment for eligible patients within the next three months.
Read more »

Labels: ,


My secret to pain free Avonex shots plus my secret to coping with Avonex side effects

Yvonne Decelis, Columnist,

I have been on Avonex since 1998. I have found that the way (for me) to make the shots as "pain free" as I can is to use something like Prilocaine/Lidocaine cream (or Emla) to numb the top layer of skin out.

Here's how I cope with the side effects of Avonex
I really hope this helps you...

Read more »

Labels: ,


Yvonne Decelis, Columnist: Today is day 5 on the "full dose" (240mg) I THINK MY MEMORY IS SHOWING SIGNS OF IMPROVEMENT! The numbness & pain my hands has subsided quite a bit, my "migraine headache" this morning went away very quickly

Today is day 5 on the "full dose Tecfidera" (240mg so far) am having no side effects and it's AWESOME (a little tired of peanut butter but LOVE not losing my weekends. I can't wait to fully get over the Avonex withdrawal and waking up)!

The numbness and pain my hands has subsided quite a bit, my "migraine headache" this morning went away very quickly and I THINK my memory is showing signs of improvement (feeling "cautiously optimistic").

Read more »

Labels: ,


Jennifer Landry, Columnist,

My Column today is about how I STOPPED TAKING AMPYRA! I now know exactly what it does for helps w overall nerve conduction so I can function & live independently.
(Stan is the Publisher of

I've been getting some HARD days Stan!! The hardest in my 20 years with ms. There was an overlap with my financial aid & I ran out of Ampyra on Sunday.

Read more »

Labels: ,


Michael Evans was diagnosed with multiple sclerosis in 2004...praises the results of an experimental drug called Alemtuzumab that he's been on since February 2011
Read more »

Labels: ,



Thank An MS Nurse: It's National Nurses Week


Doctor fined: his website claimed his products cure Cancer & MS


MSer brightens world with her photos

Karen Schiely, Akron Beacon Journal
Micheala Johanson stands in her apartment with examples of her photography work from her recent exhibit
Click to read more


Mother's MS draws daughter closer






New data show Gilenya® (fingolimod) reduced brain volume loss by one third and confirm link between brain volume loss and MS disability

Brain volume loss is emerging as a significant indicator of disability progression over the long-term in MS, and is a topic of much interest within the MS medical community.3 Loss of brain volume has been observed to occur at higher rates in patients with MS than in the general population. The average rate of brain volume loss in a person without MS over one year is 0.1% to 0.3%.

Increasingly, research focus is on treatments that will reduce the rate of brain volume loss. Fingolimod is the only NICE recommended oral treatment for RRMS that has shown early and consistent slowing of brain volume loss,5-8 and the new data presented at ECTRIMS add to the growing evidence base for fingolimod's efficacy and reinforce the correlation between brain volume loss and disability progression over the long-term.



Yvonne Decelis, Columnist,

I've written 14 columns for you.
Click on my photo on far left side
of this page to read them all

5th Place: Best Column of 2013

MY TECFIDERA FANTASTIC NEWS: My memory is improving as is some of my pain troubles & for the 1st time in 16 years I'm remembering dreams!"

Read more »



"Researchers don’t know why some multiple sclerosis therapies work"


PREGNANT? Which MS treatments are safe? Good news on Copaxone!

PREGNANT? Which MS treatments are safe? Good news on Copaxone!

"MS is a pink-ribbon disease with the majority of MSers being woman with onset of the disease during the childbearing years.
Read more »

Labels: , ,


Novartis announces data showing Gilenya slowed the rate of brain volume loss in MSers



Gilenya (Fingolimod) reduces recurrence of disease activity after Tysabri (natalizumab) withdrawal

Read more »

Labels: ,


"Good lord! I'm beating MS": How the Earl of Durham is fighting illness with a veggie diet, meditation and doses of sunshine vitamin

The inexplicable and increasingly worrying symptoms had been plaguing me for more than a year when, in December 2007, aged 46, I was diagnosed with multiple sclerosis (MS).

There had been problems with  my balance to the point where I couldn’t walk without a stick, numbness throughout my body, slurred speech and, most upsetting of all, a clumsiness in my hands that left  me unable to play the guitar. After examining my set of scans, a distinguished professor of neurology looked at me sympathetically and explained that I was among the worst new cases she had seen.
Read more »



"Which MS Drug for Which Patient? The Debate Intensifies"


Lily K. Jung Henson, MD

The European approval of alemtuzumab (Lemtrada, Genzyme/Sanofi) means that there will soon be another new and exciting tool in the multiple sclerosis (MS) armamentarium. But how will this seemingly very effective agent fit in to current treatment?

Read more »

Labels: , , ,



Important message from Beth Dean

I've written 15 Columns for you!
Read them by clicking on my 
photo on the far left
side of this page


Thank You,
Beth Dean
Drug Alert Editor
                      You'll get FREE Breaking News Drug Alerts 



Husband and wife share their story of living with her MS


Scary Health Risk for People Born in May - Netscape Home & Living

People with May birthdays may have a greater risk of developing multiple sclerosis than those born during other times of the year: Study
Click here to read more



Understanding the role of gender and hormones in multiple sclerosis

This review emphasizes that when a pregnancy is contemplated by a patient and their partner, not only the effect of gestation on the course of MS has to be discussed but also many other aspects such as the impact of MS on fertility, risk of MS in offspring, risk to the child of a parent’s MS medications before and during pregnancy, effect of MS on the ability to provide childcare and the associated socioeconomic burden to the family. Cessation of treatment prior to conception may be especially complicated in patients with previous highly active relapsing–remitting MS, particularly with newer, more potent treatments.
Click here to read more



Blood protein rejuvenates brain and muscle in old mice


Actress can't pay MS bills


Star Wars-clad characters bring the force to MS Walk



STUDY: MSers who smoke cannabis are more cognitively impaired than nonusers

"Cannabis further compromises cerebral compensatory mechanisms, already faulty in MS. These imaging data boost the construct validity of the neuropsychological findings and act as a cautionary note to cannabis users and prescribers"
Read more »

Labels: ,



The saying goes that Wales is a land of song - but the MS choir from North Wales must count as one of the most remarkable group of singers you'll find anywhere.

Every member of the choir is fighting their own battles with multiple sclerosis - and using music not just as therapy - but as a great way of entertaining people too.

Rob Shelley went to hear their music - and to hear their stories too....
Click here to watch video



21-year-old bicyclist killed riding across the country to raise money for multiple sclerosis research: Woman convicted


"REALLY FASCINATING" SAYS NEURO! Researchers make intriguing discoveries about the gut of patients with Multiple Sclerosis

Asked for her opinion of this new study, Lily Jung Hensen, MD, a neurologist at Swedish Neurosciences Institute, Seattle, Washington, said it was "really fascinating," because it may help the medical profession understand how an environmental component may have an effect on MS causation.
Read more »


ER Docs Still Rx Opioids for Migraine



Special bike boosts MSers rehab

Cycling is in Tony McAra's blood.

Read more »



THE OMG! OF THE WEEK: "Multiple Sclerosis Linked to Food Bug: Bacterial Toxin May Trigger Disease"


Three New Drugs Could Fight Autoimmune Diseases Effectively


Low-fat Diet Shows Promise in Helping Reduce MS-Related Fatigue


Medicare payment data: a no-win situation for doctors : Clinical Neurology News


Trio of research teams discover potential link between salt, genetic factors in autoimmune disease


LEMTRADA ISSUE: Genzyme and sanofi-aventis engaging in direct talks about acquisition


Gilyena gets a thumbs-up in Europe to go along with U.S. approval


AMPYRA: Extended-Release Drug Aids Walking in MS


Mystery of envelope with $2,000 in it solved

Man dropped funds for MS society off at wrong house
Read more »



Loni Anderson Reveals Daughter's Battle With MS On 'The Doctors'

Joined by her daughter Deidra, actress Loni Anderson sat down with The Doctors, and the two revealed the truth about Deidra's long battle with multiple sclerosis.
Read more »




The knowledge that epilepsy and multiple sclerosis occur together more frequently than by chance should heighten vigilance for both when diagnosing or treating patients with either condition. For example, unexplained cognitive symptoms in a patient with multiple sclerosis may turn out to be partial complex seizures, whereas an episode of painful blurry vision in someone with epilepsy could indicate optic neuritis as the first symptom of multiple sclerosis. If seizures require treatment, an antiepileptic drug should be chosen that does not exacerbate preexisting symptoms of multiple sclerosis, such as ataxia, tremor or impaired cognition.

More research needs to be done to investigate the underlying reasons for the increased incidence of epilepsy in patients with multiple sclerosis, as well as an increased incidence of multiple sclerosis in patients with epilepsy. Inflammatory cortical demyelination in multiple sclerosis could cause neuronal loss and seizures. Could an inflammatory pathogenesis of epilepsy also lead to multiple sclerosis? As research continues to progress very rapidly in both of these disease states, maybe we won't have to wait long to find out.
Read more »

Labels: , , , ,


MSers kids taken to foster care because she smoked cannabis for her Multiple Sclerosis


Teva Reports First Quarter 2014 Results for Copaxone


VIDEO: New App could help diagnose and treat multiple sclerosis

(WJBK) - Nowadays, it seems like there's an app for everything, and now, a new iPad app may help doctors diagnose and treat multiple sclerosis.

It's a test that is taken in about five minutes and measures a person's cognitive processing speed, or how quickly a person can figure out the answer to a series of simple questions. A slower time could help expose MS-related brain dysfunction.

Dr. Stephen Rao studies multiple sclerosis at Cleveland Clinic and helped develop the app. He says it could impact the way some people are diagnosed and treated.

"If a person has a relapse that involves primarily cognition, this test can then trigger a decision to put a person on a drug or change them from one drug to another," he says.

A patient will be given an iPad before their appointment and perform the test on their own in a quiet room. They'll be asked to select numbers that are paired with symbols as quickly as possible.

Story Source: The above story is based on materials provided by MYFOXDETROIT.COM
Note: Materials may be edited for content and length



Pot Eases Pain of Multiple Sclerosis, the Journal Neurology Concedes



The struggle with MS is oftentimes so personal that it is not surprising to come across family and friends who do not fully appreciate the difficulties one has to go through each day

Early intervention and treatment can greatly improve the lives of MS patients.

MULTIPLE sclerosis (MS) is a disease in which the covering of the nerves are gradually destroyed, impairing a person’s speech, sight and ability to move. It affects people between the ages of 20 and 40, and is more common in women than men.

Though MS is rare in Malaysia and Asia, it ranks among one of the leading causes of disability in young people.

Read more »


Copaxone: New version of old drug performs well in clinical trial

Tests of a new long-acting version of one of the oldest multiple sclerosis (MS) drugs on the market show it worked significantly better than placebo in reducing the number of patient relapses and developments of new or active lesions, researchers report. Most important, they add, the updated version was effective even though injections were given every two weeks instead of every other day, and it appears that fewer patients develop resistance to it.
Read more »



Treatment with Lemtrada Produces Sustained Reductions in Lesions and Brain Atrophy in Patients with Multiple Sclerosis


New test shows that women who were taking Copaxone plus estriol scored higher on cognitive tests after one year than did women who were taking Copaxone and the placebo


Biogen unveils study results confirming effectiveness of new MS treatment Plegridy

Kate Dawson, VP of Medical
       Affairs at Biogen
Biogen presented follow-up data from the second year of patients taking Plegridy, a once-a-month or once-every-other-week injected drug awaiting an approval decision in the U.S. as well as Europe. In the study, Plegridy was shown to continue helping patients manage relapses versus a placebo.

U.S. regulators accepted Biogen’s application for approval of Plegridy last July, and recently extended its deadline to approve the drug by three months. A decision is expected in coming months.
Read more »

Labels: , ,


Brain, cognitive reserve protect long-term against cognitive decline, MS researchers find




Do You Keep Seeing Patients When You're Sick?

Go to Newer News Go to Older News